コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lus bevacizumab (5 mg/kg every 2 weeks x 26, experimental group).
2 sted for proficiency on days 10, 20, and 30 (experimental group).
3 ontrol group) or FOLFOXIRI plus bevacizumab (experimental group).
4 cerebroventricular and intra-PFC) (n = 10-12/experimental group).
5 least 5 sample replicates were used for each experimental group.
6 ropriate subset of outliers to represent the experimental group.
7 tected in calretinin-positive neurons in any experimental group.
8 oluble CD40 ligand were also observed in the experimental group.
9 ion were divided into a control group and an experimental group.
10 tion time were significantly shorter for the experimental group.
11 at least five animals were assigned to each experimental group.
12 tion response to KCl and endothelin for each experimental group.
13 se bengal, riboflavin, or water according to experimental group.
14 symptoms were also better controlled in the experimental group.
15 ost-test and 3 months after post-test in the experimental group.
16 simultaneously in either the control or the experimental group.
17 neutropenia were significantly higher in the experimental group.
18 e NMDA-DeltaCa(2+) responses between the two experimental groups.
19 ges did not significantly differ between the experimental groups.
20 rol particularly LDL cholesterol observed in experimental groups.
21 levels did not significantly differ between experimental groups.
22 after attaining steady [Ca(2+)](SR) in both experimental groups.
23 essments should be identical for control and experimental groups.
24 y rats were divided among control, sham, and experimental groups.
25 able until the end of the experiment for all experimental groups.
26 ersion of CO(2) has been studied by numerous experimental groups.
27 differences in feed efficiency ratios among experimental groups.
28 /Fet-/- mice that were placed in control and experimental groups.
29 significant differences between control and experimental groups.
30 For this purpose, we first defined four experimental groups.
31 sites after 21 days differed for each of the experimental groups.
32 d XY littermates (n=8) were separated into 5 experimental groups.
33 sponse relationship was not available in all experimental groups.
34 lated OT-1/GFP group compared with all other experimental groups.
35 were present in both hemispheres of all the experimental groups.
36 rformed for comparisons between all pairs of experimental groups.
37 ovascular function compared with the other 3 experimental groups.
38 rs must control for non-random assignment to experimental groups.
39 nesis for cerebellar neurons and glia across experimental groups.
40 d hypertrophied hearts compared to all other experimental groups.
41 changes in impedance between the control and experimental groups.
42 sside induced similar relaxations in the two experimental groups.
43 /80) that are highly expressed in all of our experimental groups.
44 ined equal in other OB-layers throughout all experimental groups.
45 frequency flux noise measurements of various experimental groups.
46 ological analyses in comparison to the other experimental groups.
47 imultaneously classify samples from multiple experimental groups.
48 n of muscle samples did not differ among the experimental groups.
49 behaviors between animals in the control and experimental groups.
50 ccessibility, as compared with that of other experimental groups.
51 mab (5 mg/kg every 2 weeks for 52 weeks [ie, experimental group]).
52 insonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydr
53 Rats were randomly assigned to one of five experimental groups: 1) acutely anesthetized control, 2)
54 olled trial were randomly assigned to 1 of 3 experimental groups: 1) control, 706 mL cow milk/d plus
55 Twenty-one animals were randomized to three experimental groups: 1) Local cooling with water for 20
56 y rats were randomly assigned to one of five experimental groups: (1) control (Con), (2) 6 h of MV, (
57 d in control (group 1, periosteum alone) and experimental (group 2, periosteum with alloplastic graft
58 death occurred in 56 of 257 patients in the experimental group (21.8%), as compared with 58 of 260 p
59 rence in the risk of an unfavorable outcome (experimental group [21.0%] minus control group [17.2%])
60 response (AUC: control group 817 +/- 107 and experimental group 3,445 +/- 573 pg x ml(-1) x 90 min(-1
62 was longer, but not significantly so, in the experimental group (31.0 vs. 25.8 months; hazard ratio f
63 e curve [AUC]: control group 240 +/- 261 and experimental group 4,346 +/- 1,259 pg x ml(-1) x 90 min(
64 osis rates in 1, 2, 3, 4, and 5-years in the experimental group (6.9%, 11.5%, 19.1%, 26.0%, and 35.9%
66 ntly, the 4 and 5-year survival rates in the experimental group (83.2% and 76.3%, respectively) were
67 rticipants dropped out after assignment to 3 experimental groups; 90 participants were assigned to a
68 ed removal and replacement of individuals in experimental groups (a key method in testing for CCE) al
69 randomly assigned into one of the two 4-week experimental groups, a forced exercise group and a non-e
70 itially, 35 tumors were randomized into four experimental groups: (a) conventional monopolar RF (70 d
71 (n=8, each group) were randomized into four experimental groups: (a) conventional monopolar RF alone
73 group vs 43.1 [95% CI, 42.0 to 44.1] in the experimental group; adjusted difference, 4.9 [95% CI, 2.
74 y arch, were randomly distributed into three experimental groups administered either 1) low-dose flur
75 e-pilocarpine injections and divided into an experimental group (administered by MK-801) and a positi
76 found lower all-cause mortality risk in the experimental group after age 40 [hazard ratio (HR) = 0.9
77 ical pathway proteins did not differ between experimental groups after 3 months of diabetes, while NF
81 ts of each participant was -2.8 (7.2) in the experimental group and 10.7 (10.8) in the control group.
82 roup, among Hispanic participants (27 in the experimental group and 19 in the control group), there w
83 uction of excess arm volume was 29.0% in the experimental group and 22.6% in the control group (diffe
84 28 days, 277 of 501 patients (55.3%) in the experimental group and 251 of 509 patients (49.3%) in th
85 The objective response rate was 65% in the experimental group and 53% in the control group (P=0.006
86 75.6% (95% CI 73.7-77.5) of patients in the experimental group and 74.3% (72.3-76.2) of controls wer
88 d at euro218.30 (95%CI 150.52-286.08) in the experimental group and euro232.20 (95%CI: 203.80-260.60)
89 o compare disease-free survival between each experimental group and placebo in the intention-to-treat
90 ere not significantly different between each experimental group and the respective control group at 2
92 d-type female mice were distributed into six experimental groups and sacrificed at 7, 15, and 30 days
93 ts adhering to a particular blood type diet (experimental group) and participants continuing a standa
94 received 1 mg phylloquinone daily for 12 mo (experimental group), and 21 subjects were treated with a
95 d in the striatum or substantia nigra in any experimental group, and amphetamine-induced behavioral r
96 /lesions over time decreased slightly in the experimental group, and increased slightly in the contro
98 specimens were selected and divided into two experimental groups: animals with tough meat (TO) and an
99 n and puncture, mice were randomized to four experimental groups as follows: 1) sham control; 2) sham
101 ays (interquartile range, 4.0 to 5.0) in the experimental group, as compared with 8.0 days (interquar
102 ression-free survival was 12.1 months in the experimental group, as compared with 9.7 months in the c
103 rvings per day), declined to nearly 0 in the experimental group at 1 year, and remained lower in the
104 n the mean CAL or PD values between the four experimental groups at baseline and 3 or 12 months post-
106 s (Callithrix jacchus) were divided into two experimental groups based on their response to monocular
107 r, both measures of spatial recall separated experimental groups beyond what would be expected based
108 ant differences were noticed between the two experimental groups both for PD (P = 0.03) and clinical
109 n the standard group and 0.1 +/- 0.5% in the experimental group, but the overall time course of %BF d
110 LIMK-1, cofilin-1, and beta-actin in all the experimental groups by semiquantitative and quantitative
111 All quantitative data were compared between experimental groups by using a mixed linear model and t
112 atios (SNRs) were compared between different experimental groups by using the Kruskal-Wallis test and
113 nts were seen in 517 of 2073 patients in the experimental group compared with 539 of 2089 controls (h
114 e Short Form 36 survey, was 69 points in the experimental group compared with 58 points in the contro
115 y significant improvements in outcome in the experimental group compared with control group at both 8
117 ere significantly higher at 12 months in the experimental group compared with the control group, and
119 m-focused coping (P = 0.03) were seen in the experimental group compared with the control group.
120 alth status, and lower fatigue scores in the experimental group compared with the control group.
121 eactivity was significantly decreased in all experimental groups compared to the control groups (P <0
122 age and after 5 days of attention training (experimental group) compared with different types of no
126 luenza viruses, a ferret contact model using experimental groups comprised of one inoculated ferret a
132 assigned 30 Sprague-Dawley rats to one of 5 experimental groups: corticotomy alone, corticotomy-assi
137 p (C; no periodontal therapy) (n = 35) or an experimental group (E; NSPT in the form of scaling and r
138 archers are interested in comparing multiple experimental groups (e.g. tumor size) with a reference g
140 posure to the solution was contingent on the experimental groups entry into the goal box of the runwa
142 e randomly assigned to a control group or to experimental groups exposed to 6 or 12 h of MV with or w
143 l control, atherogenic control and six other experimental groups (fed atherogenic diet supplemented w
147 tial proficiency test, while students in the experimental group had a 91.7% pass rate at day 30 (P <
153 regulated by infection in the livers of both experimental groups; however, its levels were several-fo
154 t enzymatic degradation was observed for all experimental groups; however, statistically significant
155 ort if significant differences favouring the experimental group in a prespecified primary or secondar
156 r of replicates and the variance within each experimental group in clustering expression data, and pr
157 significant differences between control and experimental groups in both organism transcriptional act
158 ere no significant differences between the 2 experimental groups in radiographic root development ( P
159 , the effect of the person was less than the experimental group (in this case, sampling method) for a
160 Men were randomly assigned to either an experimental group, in which they took part in a task th
165 gene expression profiles that differentiate experimental groups is critical for discovery and analys
168 t, compared to controls, participants in the experimental group make more generous choices in an inde
169 ealed enhanced poly(ADP-ribosyl)ation in all experimental groups manifesting neuropathic changes.
170 atomical configurations in all zones of both experimental groups matched the functional circuit stren
171 ansected adult female rats and compared four experimental groups: media-untrained, media-trained, OEG
172 nificantly between the two groups (change in experimental group minus change in control group, -0.3;
180 took part in a task that heightened stress (experimental group, n = 41) or in which they did not tak
181 ometrically in adult Brown Norway rats (nine experimental groups; n=4-7 in each; 10-100 mmHg and sham
182 ed to the surface of sound dentin disks in 4 experimental groups: non-antibacterial adhesive and gent
183 [non-inferiority margin] at 5 years for each experimental group; non-inferiority was shown if the upp
187 focused on disease classification, comparing experimental groups of effected to normal patients.
188 n the SI cortices of both hemispheres in all experimental groups of this study suggests that a focal
192 best respiratory-system compliance (n = 501; experimental group) or a control strategy of low PEEP (n
193 help equally often from an out-group member (experimental group) or an in-group member (control group
194 January 2006 to December 2010, the covered (experimental group) or bare stent (control group) was us
195 oney over the next 4 weeks either on others (experimental group) or on themselves (control group).
196 ral feeding with an immunonutrition formula (experimental group) or standard formula (control group)
197 tients were assigned to the 4-month regimen (experimental group) or the standard regimen (control gro
202 ater than in the non-sonicated brain for all experimental groups (p<0.0001), and 1.5-fold higher for
203 umulative results during 24 months show that experimental group participants (359/648 [55%]) were mor
206 id secretion varied, the glands of all three experimental groups produced significant amounts of flui
210 f the instructive placebo procedure, the two experimental groups reached higher levels of force, beli
213 andomly assigned to one of three groups: The experimental group received an individualized telephone
218 Firefighters were randomly divided into 6 experimental groups receiving 1.2, 2.4, or 3.6 g flax oi
219 her maintained or switched resulting in four experimental groups: regular chow (R), high fat diet (H)
221 sed BH4 in retinas, lungs, and aortas in all experimental groups, resulting in a dose-dependent decre
224 esults Compared with bare nanoparticles, all experimental groups showed significantly increased negat
226 unt data were analyzed by nested ANOVA for 5 experimental groups, split-mouth controls, 3 levels alon
228 ilesional lateral geniculate nucleus in both experimental groups, suggesting that postlesion visuomot
229 es in aromatase distribution between the two experimental groups suggests that these localization pat
231 The PCB levels were reduced in all of the experimental groups tested, where addition of starter cu
232 r a control group (no thalidomide) or to the experimental group (thalidomide during induction, betwee
233 mpletion, MCP-1 levels remained lower in the experimental group than in the control group (313.88 vs
234 fatigue was also significantly lower in the experimental group than in the control group (P = 0.05).
235 verse event was significantly greater in the experimental group than in the control group (p<0.0001);
236 ents, the increase in BMI was smaller in the experimental group than in the control group after a 1-y
237 l group at 1 year, and remained lower in the experimental group than in the control group at 2 years.
239 es into holes, subjects were assigned to two experimental groups that were given different kinds of e
240 deo was shown on a tablet to children in the experimental group the afternoon preceding a planned sur
246 ately after the baseline EGG (5 pigs in each experimental group): thiopental, isoflurane, nitrous oxi
247 opulation precludes experimentation on large experimental groups, those examined in our study indicat
248 s suitable for examining differences between experimental groups, though, as with any method for imag
249 intraperitoneally before suture only in the experimental group to facilitate the fusion of the oment
251 hange in a control group with weight loss in experimental groups told to eat breakfast or to skip bre
252 ssion of CKD, we used two groups of rats: an experimental group undergoing 5/6 nephrectomy only and a
254 nts were enrolled and divided into 2 groups: experimental group (using genioplasty templates) and con
256 verse events were diarrhoea (41 [10%] in the experimental group vs five [1%] in the control group), n
259 stment for confounders, participation in the experimental group was found to be protective against jo
260 baseline activity was recorded and then the experimental group was injected with amphetamine (0.6mg/
263 strating a higher stable disease rate in the experimental group was less than 9% even under the most
264 Between-groups analyses showed that the experimental group was matched with the control group in
265 e of secondary interventional therapy in the experimental group was significantly lower than that in
268 e we observed behavioral idiosyncrasy in all experimental groups, we suspect it is present in most be
269 At 6 mo, serum ucOC concentrations in the experimental group were 0.96 +/- 0.08 ng/mL compared wit
272 patients in the placebo group and 140 in the experimental group were included in the final analysis.
273 operative time for the control group and the experimental group were nearly identical, the turnover t
275 x/ascites (6.9% vs. 16.5%, P = 0.019) in the experimental group were significantly lower than those i
278 ted ED(50) values for each fibre type within experimental groups were calculated, a significant (P<0.
284 erent commercial meat starter cultures, five experimental groups were prepared: no further addition;
288 No MMNm responses were recorded in either experimental group when stimuli were presented at SOAs f
289 p (n=6; 18 individual zones of ablation) and experimental groups where antennas were spaced 2.5 cm (n
290 4 years) were randomly assigned to either an experimental group which received a weekly subcutaneous
291 s were detected between samples derived from experimental groups which experienced fearful or neutral
293 f 10 mg/kg rifampin, followed by consecutive experimental groups with 15 patients each receiving rifa
295 rol group with uninjured lungs (n = 4) and 2 experimental groups with surfactant deactivation induced
296 e 120 min whisker stimulation period in four experimental groups with treatment initiated 0, 1, 2 (pr
297 37 cytokines increased significantly in all experimental groups, with 21 cytokines showing the highe
298 ional level, we found lower mortality in the experimental group within the strata that settled for co
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。